We have created a technology platform that allows physicians the opportunity to integrate autologous PRP (Platelet-rich Plasma) and BMCC (Bone Marrow Cell Concentrate) biologic preparations into their practice.
Learn More
The use of a patient’s own biologic preparation complements the natural healing process present in patients but is dependent on a variety of components.
Learn More
Numerous reports on potential applications for PRP and BMCC suggest that autologous PRP and BMCC preparations are considered to support a patient’s natural healing processes.
Learn More
Founder and Chief Executive Officer
Greyledge operations are currently being led by company Founder and CEO – David Karli. He is responsible for all aspects of company development, including the integration of a strong team of professionals to support Greyledge’s innovative approach to regenerative medicine.
Vice President Research and Regulatory Affairs
Dr. Sand recently joined the company to support on-going commercialization efforts, as well as initiate an active research program to advance the company’s technology platform.
Director of Operations
Mark establishes and leads many of our logistics, quality, and supporting processes as Greyledge Technologies expands its’ services throughout the United States.
Director of Training and Development
In his position as Director of Training & Development, his duties include all aspects of laboratory operations, training and providing other support to maintain Greyledge’s commitment to quality. Tim is a key element in the development and launch of new Laboratories.
